{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01531348",
      "OrgStudyIdInfo": {
        "OrgStudyId": "RP-001"
      },
      "Organization": {
        "OrgFullName": "Mahidol University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Intravitreal Injection of MSCs in Retinitis Pigmentosa",
      "OfficialTitle": "Feasibility and Safety of Adult Human Bone Marrow-Derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2012",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 2020",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 2020",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "February 6, 2012",
      "StudyFirstSubmitQCDate": "February 8, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 10, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 31, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 8, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "La-ongsri Atchaneeyasakul",
        "ResponsiblePartyInvestigatorTitle": "Professor",
        "ResponsiblePartyInvestigatorAffiliation": "Mahidol University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mahidol University",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Ministry of Health, Thailand",
            "CollaboratorClass": "OTHER_GOV"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to determine the feasibility and safety of adult human bone marrow-derived mesenchymal stem cells by intravitreal injection in patients with retinitis pigmentosa.",
      "DetailedDescription": "Retinitis pigmentosa (RP) is an inherited disorder of the photoreceptor cells in the retina. Patients may lose vision since they were young or later in life. Currently, there are more than 60 genes identified as the cause of this condition, one of which, RPE65, has been studied in several gene therapy trials for Leber congenital amaurosis with promising results. Another treatment approach for RP is stem cell therapy. Studies in animal models of RP have shown that subretinal injection of bone marrow-derived mesenchymal stem cells may delay degenerative changes of photoreceptor cells."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Retinitis Pigmentosa"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Retinitis pigmentosa",
          "Bone marrow-derived mesenchymal stem cells",
          "Intravitreal injection"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Other",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "14",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "BM-MSC",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Bone marrow-derived mesenchymal stem cells 1 million cells in balanced salt solution 100 microlitres will be injected into the vitreous cavity.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: BM-MSC"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "BM-MSC",
            "InterventionDescription": "Bone marrow-derived mesenchymal stem cells 1 million cells in balanced salt solution 100 microlitres will be injected into the vitreous cavity.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "BM-MSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Change from baseline in laser flare and cell measurements",
            "PrimaryOutcomeTimeFrame": "up to 12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Change from baseline in visual function tests",
            "SecondaryOutcomeTimeFrame": "up to 12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nRetinitis pigmentosa patients diagnosed by ophthalmologists\nAge 18-65 years old\nCentral visual field less than or equal to 20 degrees\nBest corrected visual acuity less than 6/120 by Snellen visual acuity chart\nElectroretinogram nonrecordable or the amplitudes were less than 25% of normal\n\nExclusion Criteria:\n\nOther eye conditions that could mask the interpretation of the results\nUnable to return for follow up\nUnderlying diseases including asthma, heart failure, myocardial infarction, liver failure, renal failure\nPregnant and lactating women",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "La-ongsri Atchaneeyasakul, MD",
            "OverallOfficialAffiliation": "Siriraj Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Siriraj Hospital Mahidol University",
            "LocationCity": "Bangkoknoi",
            "LocationState": "Bangkok",
            "LocationZip": "10700",
            "LocationCountry": "Thailand"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "17113430",
            "ReferenceType": "background",
            "ReferenceCitation": "Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Review."
          },
          {
            "ReferencePMID": "15565292",
            "ReferenceType": "background",
            "ReferenceCitation": "Kociok N. Can the injection of the patient's own bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa and other diseases of the eye? Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):187-8. Epub 2004 Nov 23."
          },
          {
            "ReferencePMID": "16896916",
            "ReferenceType": "result",
            "ReferenceCitation": "Arnhold S, Absenger Y, Klein H, Addicks K, Schraermeyer U. Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):414-22. Epub 2006 Aug 4."
          },
          {
            "ReferencePMID": "20169166",
            "ReferenceType": "result",
            "ReferenceCitation": "Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang QS, Grompe M, Adamus G, Appukuttan B, Lund R. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010 Feb 15;5(2):e9200. doi: 10.1371/journal.pone.0009200."
          },
          {
            "ReferencePMID": "33422139",
            "ReferenceType": "derived",
            "ReferenceCitation": "Tuekprakhon A, Sangkitporn S, Trinavarat A, Pawestri AR, Vamvanij V, Ruangchainikom M, Luksanapruksa P, Pongpaksupasin P, Khorchai A, Dambua A, Boonchu P, Yodtup C, Uiprasertkul M, Sangkitporn S, Atchaneeyasakul LO. Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Res Ther. 2021 Jan 9;12(1):52. doi: 10.1186/s13287-020-02122-7."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012173",
            "ConditionMeshTerm": "Retinitis"
          },
          {
            "ConditionMeshId": "D000012174",
            "ConditionMeshTerm": "Retinitis Pigmentosa"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012164",
            "ConditionAncestorTerm": "Retinal Diseases"
          },
          {
            "ConditionAncestorId": "D000005128",
            "ConditionAncestorTerm": "Eye Diseases"
          },
          {
            "ConditionAncestorId": "D000015785",
            "ConditionAncestorTerm": "Eye Diseases, Hereditary"
          },
          {
            "ConditionAncestorId": "D000058499",
            "ConditionAncestorTerm": "Retinal Dystrophies"
          },
          {
            "ConditionAncestorId": "D000012162",
            "ConditionAncestorTerm": "Retinal Degeneration"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14161",
            "ConditionBrowseLeafName": "Retinitis Pigmentosa",
            "ConditionBrowseLeafAsFound": "Retinitis Pigmentosa",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14160",
            "ConditionBrowseLeafName": "Retinitis",
            "ConditionBrowseLeafAsFound": "Retinitis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14151",
            "ConditionBrowseLeafName": "Retinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7423",
            "ConditionBrowseLeafName": "Eye Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17491",
            "ConditionBrowseLeafName": "Eye Diseases, Hereditary",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M28260",
            "ConditionBrowseLeafName": "Retinal Dystrophies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14149",
            "ConditionBrowseLeafName": "Retinal Degeneration",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4945",
            "ConditionBrowseLeafName": "Retinitis Pigmentosa",
            "ConditionBrowseLeafAsFound": "Retinitis Pigmentosa",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC11",
            "ConditionBrowseBranchName": "Eye Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}